TY - JOUR
T1 - Classical determinants of coronary artery disease as predictors of complexity of coronary lesions, assessed with the SYNTAX score
AU - Montero-Cabezas, J M
AU - Karalis, I
AU - Wolterbeek, R.
AU - Kraaijeveld, A. O.
AU - Hoefer, I. E.
AU - Pasterkamp, G.
AU - Pijls, N.H.
AU - Doevendans, P. A.
AU - Walterberger, J
AU - Kuiper, J.
AU - van Zonneveld, A. J.
AU - Jukema, J. Wouter
N1 - Publisher Copyright:
© The Author(s) 2017.
PY - 2017
Y1 - 2017
N2 - Background We need new biomarkers that can predict cardiovascular disease to improve both diagnosis and therapeutic strategies. The CIRCULATING CELLS study was designed to study the role of several cellular mediators of atherosclerosis as biomarkers of coronary artery disease (CAD). An objective and reproducible method for the quantification of CAD extension is required to establish relationships with these potential biomarkers. We sought to analyse the correlation of the SYNTAX score with known CAD risk factors to test it as a valid marker of CAD extension. Methods and results A subgroup of 279 patients (67.4% males) were included in our analysis. Main exclusion criteria were a history of previous percutaneous coronary intervention or surgical revascularisation that prevent an accurate assessment of the SS. Diabetes mellitus, smoking, renal insufficiency, body mass index and a history of CAD and myocardial infarction were all positively and strongly associated with a higher SYNTAX score after adjustment for the non-modifiable biological factors (age and sex). In the multivariate model, age and male sex, along with smok- ing and renal insufficiency, remain statistical significantly associated with the SYNTAX score. Conclusion In a selected cohort of revascularisation-naive patients with CAD undergoing coronary angiography, non-modifiable cardiovascular risk factors such as advanced age, male sex, as well as smoking and renal failure were independently associated with CAD complexity assessed by the SYNTAX score. The SYNTAX score may be a valid marker of CAD extension to establish relationships with potential novel biomarkers of coronary atherosclerosis.
AB - Background We need new biomarkers that can predict cardiovascular disease to improve both diagnosis and therapeutic strategies. The CIRCULATING CELLS study was designed to study the role of several cellular mediators of atherosclerosis as biomarkers of coronary artery disease (CAD). An objective and reproducible method for the quantification of CAD extension is required to establish relationships with these potential biomarkers. We sought to analyse the correlation of the SYNTAX score with known CAD risk factors to test it as a valid marker of CAD extension. Methods and results A subgroup of 279 patients (67.4% males) were included in our analysis. Main exclusion criteria were a history of previous percutaneous coronary intervention or surgical revascularisation that prevent an accurate assessment of the SS. Diabetes mellitus, smoking, renal insufficiency, body mass index and a history of CAD and myocardial infarction were all positively and strongly associated with a higher SYNTAX score after adjustment for the non-modifiable biological factors (age and sex). In the multivariate model, age and male sex, along with smok- ing and renal insufficiency, remain statistical significantly associated with the SYNTAX score. Conclusion In a selected cohort of revascularisation-naive patients with CAD undergoing coronary angiography, non-modifiable cardiovascular risk factors such as advanced age, male sex, as well as smoking and renal failure were independently associated with CAD complexity assessed by the SYNTAX score. The SYNTAX score may be a valid marker of CAD extension to establish relationships with potential novel biomarkers of coronary atherosclerosis.
KW - Coronary angiography
KW - Coronary artery disease
KW - Risk assessment
KW - Risk factors
UR - http://www.scopus.com/inward/record.url?scp=85029232107&partnerID=8YFLogxK
U2 - 10.1007/s12471-017-1005-0
DO - 10.1007/s12471-017-1005-0
M3 - Article
C2 - 28593492
SN - 1568-5888
VL - 25
SP - 490
EP - 497
JO - Netherlands Heart Journal
JF - Netherlands Heart Journal
IS - 9
ER -